Canopy Named to the New York Digital Health 100 for Second Consecutive Year
DH100 recognizes standout companies that have helped make New York the capital of healthcare innovation
Read moreDH100 recognizes standout companies that have helped make New York the capital of healthcare innovation
Read moreResearch Shows Potential to Improve Time on Treatment and Detection of High-Risk Toxicities for Blood Cancer Patients Using the Canopy Continuous Care Platform New York – Canopy, the first Continuous Care Platform for oncology, today announced findings from two studies demonstrating the clinical impact of EHR-integrated Remote Therapeutic Monitoring for patients with various hematologic malignancies. These studies demonstrate the potential of the Canopy Platform to increase time on treatment and improve detection of high-risk toxicities in patients across a variety of therapies, including bispecific antibodies.
Read moreCanopy, the first Continuous Care Platform for oncology, today announced the strategic expansion of its leadership team with the appointments of Josh Neiman as President and Chief Commercial Officer and Geoff Calkins as Chief Product and Strategy Officer. With these strategic appointments, Canopy is poised to strengthen its leadership position in the oncology space and deliver on its mission to provide comprehensive, continuous care solutions that empower practices and improve patient outcomes.
Read moreFacilitating the Safe Integration of Bispecific Antibodies into Community Oncology
Read moreNew partnership aims to operationalize continuous care management The Toledo Clinic Cancer Centers (TTCCC), a multi-specialty oncology practice and member of ONCare Alliance, today announced a partnership with Canopy, the first Intelligent Care Platform for oncology, to further enhance patient outcomes through continuous care management.
Read more
Research Demonstrates Improved High-Risk Symptom Detection, Comparable Outcomes with ePRO Compared to Phone Triage New York, New York - Canopy, the first Continuous Care Platform for oncology, today announced results from a three-year, real-world study demonstrating improved detection of high-risk symptoms and comparable outcomes for patients using an electronic patient-reported outcomes (ePRO) tool compared to telephone triage.
Read more
Jan 01 2023

Nov 07 2022

Sep 06 2022

Mar 19 2022

Mar 18 2022

Mar 17 2022

Mar 17 2022